PAR paradigm biopharmaceuticals limited..

Ann: Notice of General Meeting/Proxy Form, page-35

  1. 286 Posts.
    lightbulb Created with Sketch. 102
    The interim analysis was always expected to be after the expiry date of the options.

    I sold $75K in PAR shares @ 50c to buy $42K in PAROA @ 15c, which means if by February 2026 PAR's share price is below 22c or above ~76c (assuming σ_PBO=100%), I'll be better off than if I'd held onto my PAR shares.

    Unlike you I don't believe there is a "well over 50% chance" that the share price will be under ~60c in February 2026...

    I don't understand why you, Gan_Gans, and m9 remain PAR shareholders when you think PAR have almost no chance of doing a deal. Do you really think that PAR can fund the trial through to Interim Analysis by doing capital raises at sub 20c? Even issuing 100M shares at 20c will only raise A$20M.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
30.5¢
Change
-0.015(4.69%)
Mkt cap ! $118.7M
Open High Low Value Volume
32.0¢ 32.0¢ 30.0¢ $155.3K 501.9K

Buyers (Bids)

No. Vol. Price($)
1 6563 30.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 96132 4
View Market Depth
Last trade - 16.10pm 30/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.